Leading the Way in Life Science Technologies

GEN Exclusives

More »

Feature Articles

More »

For full access to this article login to GEN Select now.

May 15, 2014 (Vol. 34, No. 10)

Small Molecules, Big Possibilities

  • Selective, targeted small molecule drug candidates are moving through the clinical development pipeline in a range of disease indications. While the current generation of small molecule drugs in clinical trials share some key advantages with small molecule therapeutics already on the market, such as oral bioavailability and less ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.